The association of surgical volume with postoperative results has been studied primarily on demanding oncological surgical procedures. These studies have shown significant lower rates of postoperative morbidity and mortality in highvolume centers. [1] [2] [3] Esophageal achalasia is a rare disease, and it is unknown if a surgeon's volume affects the postoperative results. Therefore, we aimed to characterize the trend of utilization of esophagomyotomy stratified by surgical volume in the United States and to analyze the association of surgical volume with perioperative outcomes.
Methods | A retrospective population-based analysis was performed using the National (Nationwide) Inpatient Sample for the period January 1, 2000, through December 31, 2013. This study was approved by the University of North Carolina Institutional Review Board as exempt research, and patient informed consent was waived because the study used deidentified data. Data were collected from January 10, 2017, to February 1, 2017. Data analysis took place from February 2, 2017 , to March 15, 2017 Adult patients aged 18 years or older who were diagnosed with esophageal achalasia and who underwent esophagomyotomy were included. Hospital surgical volume was determined using the 30th and 60th percentile cut points for weighted discharges and was classified as low volume (<5 operations per year), intermediate volume (5-10 operations per year), or high volume (>10 operations per year).
The yearly incidence of esophagomyotomy, stratified across hospital volume, was calculated using Poisson regression. Patient demographics and outcomes were compared across surgical volume using χ 2 and Wilcoxon or MannWhitney tests, where appropriate. Missing data were estimated using Markov Chain Monte Carlo multiple imputation. Main-effect multivariable analyses on the potential influence of surgical volume on patient outcomes were performed using logistic regression on the imputed data sets. All analyses were performed using SAS software, version 9.4 (SAS Institute Inc). A 2-sided P < .05 was considered statistically significant.
Results | A total of 7488 patients were included. During the study period, 5278 patients (70.5%) underwent esophagomyotomy in high-volume hospitals, 1349 (18.0%) in intermediatevolume hospitals, and 861 (11.5%) in low-volume hospitals. Use of the laparoscopic approach was significantly different among the 3 groups, with 360 patients (36.0%) using it in low-volume hospitals, 567 (42.0%) in intermediate-volume hospitals, and 2631 (49.9%) in high-volume hospitals (P < .001). Demographic and patient characteristics, stratified by hospital volume, are described in Table 1 .
Between January 1, 2000, and December 31, 2013, the percentage of procedures occurring at high-volume hospitals increased from 70.5% to 82.5%, whereas the percentage of procedures at low-volume hospitals decreased from 13.9% to 7.8% and at intermediate-volume hospitals from 15.6% to 9.7%.
Compared with high-volume hospitals, low-and intermediate-volume hospitals had a significantly higher incidence of complications. Specifically, patients at low-and intermediatevolume hospitals had higher rates of postoperative bleeding, cardiac failure, renal failure, and respiratory failure. In addition, high-volume hospitals were associated with shorter length of hospital stay ( Table 2) .
After adjusting for patient and hospital characteristics, we found that patients receiving care at low-volume hospitals (odds ratio [OR], 1.37) were still more likely to have postoperative complications, compared with patients at highvolume hospitals. Patients at low-and intermediate-volume hospitals were more likely to have postoperative respiratory failure. Patients at low-volume hospitals had a median (interquartile range) length of stay of 3 (2-6) days or stayed 1.27 days longer than did patients at high-volume centers, and patients at intermediate-volume hospitals also had a median (interquartile range) length of stay of 3 (2-6) days or stayed 0.63 days longer (Table 2) .
Discussion | During the study period, most surgical treatments for esophageal achalasia in the United States were performed in high-volume centers. Patients receiving care at high-volume hospitals had a lower incidence of postoperative respiratory complications and shorter length of hospital stay. In addition, high surgical volume was associated with higher rates of minimally invasive surgery. Laparoscopic surgery, in fact, has proven to be associated with significantly better postoperative outcomes and lower costs in patients with other benign esophageal disorders. 4, 5 Even though it is hard to legislate, volume standards should be implemented for a rare disease such as esophageal achalasia and centers of excellence should be designated for its treatment. These recommendations might benefit both patients and the US health care system. 
Trends in Country-Specific Surgical Randomized Clinical Trial Publications
Historically, the United States was at the forefront of surgical discovery, as measured by publications and citations. 1 A decline in surgical study publications was seen from 2000 to 2010, the drivers of which were hypothesized to be the external and internal pressures from stagnating US funding and the inefficiencies in translating funds into published work. 1-3 Randomized clinical trials (RCTs) are vital to discovery. We describe trends in country-specific surgical RCT publications in preeminent international journals to generate and inform the dialogue between surgical researchers and funding agencies in the United States. 4 Trials by country were normalized to the number per 100 000 population and to the amount of government-only gross domestic spending on research and development (R&D). 5-7 These ratios are proxy measurements for an individual country's rate of publication and the efficiency of government spending on surgical R&D. (Table) .
Discussion | Randomized clinical trials require substantial financial and organizational investment. Historically, the United States excelled in its capacity and influence in surgery. Although it remains the world leader in overall number of surgical RCTs published, it has stagnated and is now behind most of Western Europe in per capita publications. Of concern, especially in the United States, is a global trend toward a decreased number of surgery RCTs per government R&D investment. Influencers of this trend could include the diminished allocation of research dollars to surgery or the inefficiencies in translating funding into publications. The inefficiency of surgical RCTs is a concern; a third of RCTs remain unpublished, and 20% of trials are discontinued at 5 years, most commonly owing to insufficient patient recruitment. 3 It was not possible to determine causation in this analysis. Regardless, action and intervention are necessary to ensure continued government funding and to improve the efficiency of RCTs so that they are published. Published surgical research is essential for improving surgical practice and increasingly must be accomplished in financially constrained environments. As a surgical community, we must critically analyze and improve the use of research investments. The rate of nonpublication and the amount of trial discontinuations due to insufficient patient recruitment highlight a poor functioning system. If the United States wants to regain its preeminence in surgical research, prompt action is necessary to improve dedicated surgical RCT funding and to transform the US surgical research system into one designed for efficiency.
